Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 202666
Company: TWI PHARMS
Company: TWI PHARMS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 30MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | AB | No | No |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 60MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 09/16/2022 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 08/14/2025 | SUPPL-9 | Labeling-Patient Package Insert |
Label is not available on this site. |
||
| 08/14/2025 | SUPPL-8 | Labeling-Patient Package Insert |
Label is not available on this site. |
DEXLANSOPRAZOLE
CAPSULE, DELAYED RELEASE;ORAL; 30MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DEXILANT | DEXLANSOPRAZOLE | 30MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | Yes | AB | 022287 | TAKEDA PHARMS USA |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 30MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | No | AB | 219115 | ALEMBIC |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 30MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | No | AB | 205205 | MYLAN |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 30MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | No | AB | 202294 | PH HEALTH |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 30MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | No | AB | 202666 | TWI PHARMS |
CAPSULE, DELAYED RELEASE;ORAL; 60MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DEXILANT | DEXLANSOPRAZOLE | 60MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | Yes | AB | 022287 | TAKEDA PHARMS USA |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 60MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | No | AB | 219115 | ALEMBIC |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 60MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | No | AB | 205205 | MYLAN |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 60MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | No | AB | 202294 | PH HEALTH |
| DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 60MG | CAPSULE, DELAYED RELEASE;ORAL | Prescription | No | AB | 202666 | TWI PHARMS |